相似文献/References:
[1]王虹 吉雷 刘远光 周萍萍 张鹏 王冬兰.结缔组织生长因子在2型糖尿病大鼠虹膜中的表达[J].眼科新进展,2012,32(2):000.
[2]李姣 王兴荣 崔彦 刘正峰 王影 李洋.雷珠单抗选择性体外抑制睫状体恶性黑色素瘤[J].眼科新进展,2013,33(11):000.
[3]金昱,石安娜,刘淼. 玻璃体内注射雷珠单抗(Ranibizumab)治疗视网膜静脉阻塞继发黄斑水肿[J].眼科新进展,2014,34(9):855.[doi:10.13389/j.cnki.rao.2014.0236]
[4]张聪,刘东宁,徐丽. 玻璃体内注射Lucentis治疗中心性渗出性脉络膜视网膜病变的临床疗效[J].眼科新进展,2014,34(9):864.[doi:10.13389/j.cnki.rao.2014.0239]
[5]章晖,叶波,邱新文,等.雷珠单抗辅助23G玻璃体切割术治疗增生性糖尿病视网膜病变[J].眼科新进展,2014,34(10):975.[doi:10.13389/j.cnki.rao.2014.0270]
[6]王博,吴京,马明,等. 玻璃体内注射雷珠单抗与曲安奈德治疗糖尿病黄斑水肿的疗效对比分析[J].眼科新进展,2015,35(3):246.[doi:10.13389/j.cnki.rao.2015.0066]
WANG Bo,WU Jing,MA Ming,et al. Clinictid effect comparison of intravitreal lucentis and triamcinolone acetonide for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(6):246.[doi:10.13389/j.cnki.rao.2015.0066]
[7]刘斌,杨玉霞,刘杏,等. 雷珠单抗联合Ahmed青光眼阀植入术治疗新生血管性青光眼[J].眼科新进展,2015,35(3):263.[doi:10.13389/j.cnki.rao.2015.0070]
LIU Bin,YANG Yu-Xia,LIU Xing,et al. Intravitreal lucentis injection combined with Ahmed valve implantation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(6):263.[doi:10.13389/j.cnki.rao.2015.0070]
[8]詹冬梅,史琴,哈玲芳,等. 两种联合术式人工晶状体植入术治疗增生性糖尿病视网膜病变的对比研究[J].眼科新进展,2015,35(3):266.[doi:10.13389/j.cnki.rao.2015.0071]
ZHAN Dong-Mei,SHI Qin,HA Ling-Fang,et al. Comparative study of vitrectomy combined with phacoemulsification or pars plana lensectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(6):266.[doi:10.13389/j.cnki.rao.2015.0071]
[9]刘志南,邓国华,江一. 光凝前雷珠单抗玻璃体内注射对CNV患者黄斑区视网膜及视功能的影响[J].眼科新进展,2015,35(4):365.[doi:10.13389/j.cnki.rao.2015.0098]
LIU Zhi-Nan,DENG Guo-Hua,JIANG Yi. Effects of ranibizumab intravitreal injection before photocoagulation on macular retina and visual function in patients with CNV[J].Recent Advances in Ophthalmology,2015,35(6):365.[doi:10.13389/j.cnki.rao.2015.0098]
[10]万文萃,刘宇莹,尹向可,等. 玻璃体内注射抗血管内皮生长因子药物治疗急进性后部型早产儿视网膜病变[J].眼科新进展,2015,35(6):554.[doi:10.13389/j.cnki.rao.2015.0150]
WAN Wen-Cui,LIU Yu-Ying,YIN Xiang-Ke,et al. Intravitreal injection of ranibizumab for aggressive posterior retinopathy of prematurity[J].Recent Advances in Ophthalmology,2015,35(6):554.[doi:10.13389/j.cnki.rao.2015.0150]